AUAUniversity Podcast Series: Episode No. 72
GU Podcast (2020): Targeted Therapies and Integration with Surgical Management of RCC
At the conclusion of this activity, participants will be able to:
- Describe new and emerging targeted for patients with locally-advanced and advanced kidney cancer and the role of adjuvant therapy.
- Review the mechanisms of action, efficacy, and safety of currently available targeted treatment of RCC.
- Facilitate discussions with patients and caregivers regarding RCC treatment options.
This educational series is supported by independent educational grants from:
Bristol Myers Squibb
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
UroGen Pharma, Inc